Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

[1]  Stephanie Roessler,et al.  MicroRNA expression, survival, and response to interferon in liver cancer. , 2009, The New England journal of medicine.

[2]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[3]  C. Mackay,et al.  The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. , 2009, Immunity.

[4]  Xinxia Peng,et al.  Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers , 2009, BMC Genomics.

[5]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[6]  A. Baranova,et al.  Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin , 2009, Hepatology.

[7]  Yoshiki Murakami,et al.  Regulation of the hepatitis C virus genome replication by miR-199a. , 2009, Journal of hepatology.

[8]  G. Soukup,et al.  MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes12 , 2009, The Journal of Immunology.

[9]  Edward A Belongia,et al.  National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.

[10]  W. Filipowicz,et al.  Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy , 2009, Nature Medicine.

[11]  A. Pivarcsi,et al.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. , 2008, Seminars in cancer biology.

[12]  B. Pulendran,et al.  Division of labor, plasticity, and crosstalk between dendritic cell subsets. , 2008, Current opinion in immunology.

[13]  M. Cam,et al.  Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response , 2007, Hepatology.

[14]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[15]  T. Asselah,et al.  Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C , 2007, Gut.

[16]  Yoshiyuki Suzuki,et al.  Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia , 2007, Intervirology.

[17]  T. Nilsen,et al.  Mechanisms of microRNA‐mediated gene regulation , 2007, Trends in genetics : TIG.

[18]  Hsien-Da Huang,et al.  ViTa: prediction of host microRNAs targets on viruses , 2006, Nucleic Acids Res..

[19]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[20]  J. McHutchison,et al.  American Gastroenterological Association technical review on the management of hepatitis C. , 2006, Gastroenterology.

[21]  R. Pillai.  MicroRNA function: multiple mechanisms for a tiny RNA? , 2005, RNA.

[22]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[23]  Phillip D. Zamore,et al.  Ribo-gnome: The Big World of Small RNAs , 2005, Science.

[24]  D. Dhumeaux,et al.  Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. , 2005, Journal of hepatology.

[25]  Chris Sander,et al.  The developmental miRNA profiles of zebrafish as determined by small RNA cloning. , 2005, Genes & development.

[26]  Limin Chen,et al.  Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. , 2005, Gastroenterology.

[27]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[28]  H. Rosen,et al.  Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease , 2004, Hepatology.

[29]  Sandrine Dudoit,et al.  Bagging to Improve the Accuracy of A Clustering Procedure , 2003, Bioinform..

[30]  J. Hoofnagle,et al.  National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002 , 2002, HIV clinical trials.

[31]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[32]  S. Dudoit,et al.  A prediction-based resampling method for estimating the number of clusters in a dataset , 2002, Genome Biology.

[33]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[34]  G. V. Ommen,et al.  Medical genomics , 2001, European Journal of Human Genetics.

[35]  Eugene R. Schiff,et al.  National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.

[36]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.